Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02027909 · ClinicalTrials.gov registry record
A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction
A clinical trial of Sinus Node Dysfunction, sponsored by Arun Rao.
- Completed
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT02027909 is a study of Sinus Node Dysfunction that has completed, run by Arun Rao. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02027909, a study of Sinus Node Dysfunction, has completed, sponsored by Arun Rao.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Providing ideal rate response to patients should improve their quality of life and ability to execute activities of daily living. Medtronic pacemakers provide rate response pacing by utilizing dual zone programming to specify an "activities of daily living" (ADL) response rate and an "exertion" response rate. There is much data to support the target heart rate for an exercise response but the data to support the programming of the ADL rate is lacking.
Conditions Studied
Interventions
- DEVICE Reprogramming dual chamber pacemaker
Study Locations (1)
Tennessee
- Wellmont CVA Heart Institute - Kingsport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02027909
The ClinicalTrials.gov registry entry for NCT02027909 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arun Rao, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sinus Node Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Reprogramming dual chamber pacemaker is the first listed.
NCT02027909 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT02027909 about?
NCT02027909 is a clinical study titled "A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction". Providing ideal rate response to patients should improve their quality of life and ability to execute activities of daily living. Medtronic pacemakers provide rate response pacing by utilizing dual zone programming to specify an "activities of daily living" (ADL) response rate and an "exertion" res...
What is the current status of trial NCT02027909?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2011-11. Estimated completion is 2015-04.
What conditions does trial NCT02027909 study?
This clinical trial studies the following conditions: Sinus Node Dysfunction.
What interventions are being tested in trial NCT02027909?
The interventions under investigation include: Reprogramming dual chamber pacemaker (DEVICE).
Who is sponsoring clinical trial NCT02027909?
This trial is sponsored by Arun Rao, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02027909 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sinus Node Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.